- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 0
- Grants since 2016
- 3 213
Grants received
2022–2027 · cooperative agreement · U54
Administrative Core
Christina S Leslie · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Biospecimen Core
Olca Basturk · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives
Eileen Mary O'Reilly · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Clinical Practice Network
Peter D Stetson · Kettering University · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Project I: Systems analysis of tumor-stroma interactions in brain metastasis
Joan Massague · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Administrative Core
Christine A Iacobuzio-Donahue · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Research & Methods Core
Katherine S Panageas · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Recombinant Interleukin-33 Immunotherapy for Pancreatic Cancer
Vinod P Balachandran · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Developmental Research Program
Jason S. Lewis · Kettering University · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Data Infrastructure Core
John Damon Chodera · Kettering University · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Outreach Core
Wesley Tansey · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Career Enhancement Program
Christine A Iacobuzio-Donahue · Kettering University · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Covalent targeting strategies
John Damon Chodera · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Biospecimen Core
Olca Basturk · Kettering University · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Structural Biology Core
John Damon Chodera · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Administrative Core
Katherine S Panageas · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Total Neoadjuvant Therapy (TNT) for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Alice Chia- Chi Wei · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Career Enhancement Program
Christine A Iacobuzio-Donahue · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Pragmatic Trial
Michael J Morris · Kettering University · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Target enablement
John Damon Chodera · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Biostatistics Core
Marinela Capanu · Kettering University · funded by National Institutes of Health
2021–2027 · career development · K00
Dissecting mechanisms of inflammation driven cancer susceptibility in epithelial barrier tissues
Christopher Cowley · Kettering University · funded by National Institutes of Health
2021–2025 · research · R01
Lipotoxic Protective Response of the Endoplasmic Reticulum
Robert V Farese · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Improving efficacy of radioiodine treatment of thyroid cancer
James A Fagin · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons
Doron Betel · Kettering University · funded by National Institutes of Health
2021–2026 · research · R35
Sizing and Scaling in Functional Muscle Cells
Mary K Baylies · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Empathic Communication Skills Training to Reduce Lung Cancer Stigma
Smita Banerjee · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Transcriptional control of NK cell metabolism
Joseph Chai-Yuen Sun · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Transcriptional control of NK cell metabolism
Joseph Chai-Yuen Sun · Kettering University · funded by National Institutes of Health
2021–2024 · fellowship · F31
Investigating the role of fatty acid metabolism in melanocyte differentiation: Insights into the metabolic requirements of development
Eleanor May Johns · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
A Phase 1 Trial of MLN0128 (sapanisertib) and CB-839 HCl (telaglenastat) in Advanced NSCLC Patients
Paul K Paik · Kettering University · funded by National Institutes of Health
2021–2024 · research · R01
Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes
Katharine C Hsu · Kettering University · funded by National Institutes of Health
2021–2022 · career development · K99
Mechanistically Dissecting Glycolysis Regulation by Lactate and Its Therapeutic Potential in Cancer
Xin Cai · Kettering University · funded by National Institutes of Health
2021–2025 · research · R01
Ceramide-Rich Platforms Functionalize Gemcitabine Uptake
Richard N Kolesnick · Kettering University · funded by National Institutes of Health
2021–2025 · research · R37
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture
Simone Krebs · Kettering University · funded by National Institutes of Health
2021–2022 · research · R01
Targeting replication stress signaling to overcome immune evasion in small cell lung cancer
Triparna Sen · Kettering University · funded by National Institutes of Health
2021–2023 · research · R03
Understanding the Guideline-Discordant Use of Bone Modifying Agents in Prostate Cancer
Aaron P Mitchell · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Investigating PolQ-mediated alternative NHEJ in breast cancer
Agnel Sfeir · Kettering University · funded by National Institutes of Health
2021–2026 · career development · K08
A Targeted Approach to the Surveillance of Precursor Lesions for Gastric Cancer
Monika Laszkowska · Kettering University · funded by National Institutes of Health
2021–2024 · research · R01
Harnessing Rare Variants for Tumor Classification
Colin B Begg · Kettering University · funded by National Institutes of Health